CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
93.40
-2.50 (-2.61%)
Apr 29, 2026, 1:30 PM CST
23.71%
Market Cap 9.60B
Revenue (ttm) 1.82B
Net Income (ttm) 464.00M
Shares Out 102.80M
EPS (ttm) 4.50
PE Ratio 20.76
Forward PE n/a
Dividend 4.80 (5.01%)
Ex-Dividend Date Mar 26, 2026
Volume 110,180
Average Volume 288,116
Open 96.60
Previous Close 95.90
Day's Range 93.40 - 96.60
52-Week Range 75.00 - 123.50
Beta 0.10
RSI 48.12
Earnings Date May 6, 2026

About CH Biotech R&D

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2025, CH Biotech R&D's revenue was 1.82 billion, an increase of 11.21% compared to the previous year's 1.64 billion. Earnings were 464.00 million, a decrease of -2.60%.

Financial Statements

News

There is no news available yet.